Langhoff R, Schulte K-L
Ev. Krankenhaus Königin Elisabeth Herzberge, Gefässzentrum Berlin/Medizinische Klinik, Akademisches Lehrkrankenhaus der Humboldt-Universität, Herzbergstr. 79, 10365 Berlin.
Hamostaseologie. 2006 Aug;26(3):208-13.
With regards to the rapid progress of interventional therapy in the treatment of PAOD the revision of the published guidelines (TASC Recommendations 2000) is more than necessary. The current options in therapy are modified constantly. Therefore, published recommendations might be not up-to-date. In consideration of the number of interventions and operations which are performed throughout Europe a trend towards less invasive treatment becomes apparent. Guidelines and recommendations from the Charing Cross and the ACC/AHA (ACC/AHA Guidelines for the Management of Patients With Peripheral Arterial Disease 2005) are reflecting this development. Regardless of the complexity of the planned procedure interventional treatment is almost always first choice therapy. A yearly revision of the actual guidelines would be useful, leading to an up-to-date modality. Although in the diagnostic pathway MRI and CTA gain more importance, the gold standard in diagnosis of PAOD remains the standardised measurement of the walking capacity, ankle-brachial index (ABI) and duplex ultrasound.
鉴于介入治疗在治疗下肢动脉硬化闭塞症(PAOD)方面的迅速进展,修订已发表的指南(2000年TASC建议)非常必要。当前的治疗选择在不断变化。因此,已发表的建议可能不再适用。考虑到在整个欧洲进行的介入治疗和手术数量,微创治疗的趋势变得明显。来自查林十字医院和美国心脏病学会/美国心脏协会(ACC/AHA,2005年外周动脉疾病患者管理ACC/AHA指南)的指南和建议反映了这一发展。无论计划的手术复杂程度如何,介入治疗几乎总是首选治疗方法。每年修订实际指南将是有益的,可形成最新的治疗模式。尽管在诊断途径中,磁共振成像(MRI)和CT血管造影(CTA)变得更加重要,但PAOD诊断的金标准仍然是步行能力、踝臂指数(ABI)和双功超声的标准化测量。